Revenue: US$84.5m (down 55% from 3Q 2023). Net loss: US$121.3m (loss narrowed by 7.2% from 3Q 2023). US$0.76 loss per share ...

Wall Street's three major indexes closed lower on Tuesday as investors booked some profits from a post-election rally and ...

Richmond Fed President Thomas Barkin said earlier in the day that the U.S. central bank is ready to respond if inflation ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Tuesday reported a loss of $121.3 million in its third quarter. On a per-share basis, the Gaithersburg, Maryland-based company ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

Investing.com - The U.S. dollar traded in tight ranges Thursday, as traders digested some mixed economic data ahead of the widely-watched payrolls report which closes out the week. At 05:35 ET (09 ...

To send us a question in advance of next week’s show, write to: [email protected]. Tune in live Monday mornings at 7:30am Pacific at kpfa.org Podcast music credit: Now Son by Podington Bear, licensed ...

JP Morgan has recently reduced Novavax Inc (NVAX) stock to Underweight rating, as announced on July 30, 2024, according to Finviz. Earlier, on May 10, 2024, JP Morgan had raised the stock from a ...

About a week later, the agency authorized an updated version of Novavax’s protein subunit vaccine for people 12 years and older. The mRNA vaccines specifically target KP.2, a subvariant of JN.